Radicool Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 06-07-2024
- Paid Up Capital ₹ 7.70 M
as on 06-07-2024
- Company Age 11 Year, 1 Day
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.71 Cr
as on 06-07-2024
- Satisfied Charges ₹ 1.53 Cr
as on 06-07-2024
- Revenue 36.22%
(FY 2023)
- Profit 13.41%
(FY 2023)
- Ebitda 20.99%
(FY 2023)
- Net Worth 54.62%
(FY 2023)
- Total Assets 18.30%
(FY 2023)
About Radicool Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.70 M.
The company currently has active open charges totaling ₹5.71 Cr. The company has closed loans amounting to ₹1.53 Cr, as per Ministry of Corporate Affairs (MCA) records.
Beena Rawat and Lalit Singh serve as directors at the Company.
- CIN/LLPIN
U51101DL2014PTC263647
- Company No.
263647
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jan 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Radicool Pharmaceutical Private Limited offer?
Radicool Pharmaceutical Private Limited offers a wide range of products and services, including Health Conditions, Heart Care, Women Care, Mother Care.
Who are the key members and board of directors at Radicool Pharmaceutical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Beena Rawat  | Director | 16-Jan-2014 | Current |
| Lalit Singh | Director | 16-Jan-2014 | Current |
Financial Performance of Radicool Pharmaceutical.
Radicool Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 36.22% increase. The company also saw a substantial improvement in profitability, with a 13.41% increase in profit. The company's net worth Soared by an impressive increase of 54.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Radicool Pharmaceutical?
In 2023, Radicool Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Oct 2023 | ₹1.00 M | Open |
Axis Bank Limited Creation Date: 22 Aug 2023 | ₹1.53 Cr | Open |
Axis Bank Limited Creation Date: 01 Aug 2023 | ₹1.00 Cr | Open |
How Many Employees Work at Radicool Pharmaceutical?
Radicool Pharmaceutical has a workforce of 21 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Radicool Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Radicool Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
